A comprehensive review found substantial evidence supporting cannabinoid efficacy for chronic pain and multiple sclerosis symptoms, while noting important adverse effects and the need for careful patient selection.
Read this if you are considering medical cannabis and want a balanced overview of what the evidence supports and what risks to be aware of.
Chronic cancer/neuropathic pain and MS symptoms have "substantial evidence" for cannabinoid efficacy.
What the researchers found
This review covered the medical evidence for cannabinoid therapeutics across multiple conditions. Chronic cancer pain, neuropathic pain, and certain MS symptoms had the strongest evidence supporting cannabinoid efficacy. For these conditions, well-characterized cannabinoid medications have met FDA standards.
The review emphasized patient selection as critical: cannabinoid therapy is most appropriate when standard treatments have failed for a debilitating condition. Physicians certifying medical cannabis must inform patients about acute effects (impaired memory, coordination, and judgment), potential chronic effects (cannabis use disorder, cognitive impairment, chronic bronchitis), and social risks (workplace issues, driving impairment).
The review also noted that novel approaches to manipulating the endocannabinoid system are being explored to maximize benefits while minimizing harmful effects, moving beyond simply administering THC.
Why it matters
As medical cannabis programs expand, physicians need clear guidance on where the evidence supports use and how to counsel patients about risks. This review provides that framework, distinguishing between conditions with strong evidence and those with insufficient data.
The numbers in context
Chronic cancer and neuropathic pain and certain MS symptoms had substantial evidence. Cannabis use disorder, cognitive impairment, and chronic bronchitis are documented chronic risks. Acute risks include impaired memory, coordination, judgment, and increased motor vehicle accident risk.
How the study worked
Comprehensive narrative review published in Annals of Medicine, covering the history of medical cannabis, the endocannabinoid system, approved cannabinoid medications, medical conditions with evidence, adverse effects, and physician certification considerations.
What this study cannot tell us
Narrative review format means the evidence selection and interpretation reflect the authors' perspective. The review predates several large clinical trials and regulatory changes. The rapid evolution of cannabis products (higher potency, new delivery methods) may not be fully captured.
How to read the evidence
Moderate evidence from a comprehensive narrative review synthesizing clinical trial data, approved indications, and risk assessments.
When this study was published
Published in 2016. The medical cannabis evidence landscape has evolved significantly with additional clinical trials and regulatory approvals.
The bigger picture
The review captures a pivotal moment in medical cannabis: sufficient evidence exists for specific conditions to justify use, but the evidence base does not support the broad claims often made by medical cannabis advocates. The emphasis on patient selection criteria and informed consent reflects the medical establishment's effort to integrate cannabinoid therapy responsibly.
Questions still open
- Has the evidence base for medical cannabis expanded since 2016 to include additional conditions? How do newer cannabinoid formulations compare to older ones for efficacy and safety? What is the optimal framework for physician certification of medical cannabis patients?
Common questions
What conditions have the strongest evidence for medical cannabis?
What are the main risks of medical cannabis?
Read the original research
Cannabinoids: Medical implications.
Annals of medicine, 48(3), 128-41
Citation
Schrot, Richard J; Hubbard, John R. (2016). Cannabinoids: Medical implications.. Annals of medicine, 48(3), 128-41. https://doi.org/10.3109/07853890.2016.1145794
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk